Innoviva Inc (INVA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
17.39 unch (unch) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 17.39 unch (unch) 16:03 ET
for Fri, Mar 14th, 2025
Results
download Want to compare other data? Select FieldsSymbol | INVA | LLY | JNJ | ABBV | NVO |
Company | Innoviva Inc | Eli Lilly and Company | Johnson & Johnson | Abbvie Inc | Novo Nordisk A/S ADR |
Price Information | |||||
Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
Open | 17.38 | 803.11 | 162.12 | 209.78 | 75.75 |
High | 17.52 | 815.21 | 163.15 | 212.82 | 77.55 |
Low | 17.31 | 800.00 | 161.10 | 208.29 | 75.24 |
Last | 17.39 | 813.48 | 162.81 | 211.77 | 77.15 |
Change | unch | +11.83 | -0.18 | +0.22 | +1.26 |
% Change | unch | +1.48% | -0.11% | +0.10% | +1.66% |
Volume | 972,500 | 3,102,300 | 6,235,700 | 4,511,500 | 6,505,900 |
20-Day Average Volume | 925,685 | 3,696,560 | 9,636,295 | 6,348,715 | 8,065,475 |
Previous Close | 17.39 | 801.65 | 162.99 | 211.55 | 75.89 |
Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 17.76 | 874.15 | 163.26 | 206.81 | 84.71 |
20-Day Raw Stochastic | 24.60% | 12.91% | 57.13% | 75.39% | 16.75% |
20-Day Relative Strength | 38.47% | 43.51% | 56.86% | 66.61% | 39.35% |
Weighted Alpha | +9.51 | +2.79 | +5.80 | +24.91 | -47.21 |
Today's Opinion | 88% Sell | 40% Sell | 40% Buy | 100% Buy | 88% Sell |
Previous Opinion | 88% Sell | 40% Sell | 56% Buy | 100% Buy | 88% Sell |
Last Month's Opinion | 32% Sell | 8% Buy | 8% Sell | 40% Buy | 100% Sell |
Performance | |||||
5-Days | |||||
%Chg | -1.42% since 03/07/25 | -6.45% since 03/07/25 | -2.33% since 03/07/25 | -1.18% since 03/07/25 | -11.49% since 03/07/25 |
Low | 17.00 on 03/13/25 | 795.38 on 03/13/25 | 161.10 on 03/14/25 | 208.29 on 03/14/25 | 73.80 on 03/12/25 |
High | 17.91 on 03/10/25 | 863.19 on 03/10/25 | 169.90 on 03/10/25 | 218.66 on 03/10/25 | 80.70 on 03/10/25 |
1-Month | |||||
%Chg | -3.82% since 02/14/25 | -3.65% since 02/14/25 | +4.27% since 02/14/25 | +9.80% since 02/14/25 | -0.92% since 02/14/25 |
Low | 17.00 on 03/13/25 | 795.38 on 03/13/25 | 153.24 on 02/18/25 | 190.67 on 02/18/25 | 73.80 on 03/12/25 |
High | 18.57 on 02/27/25 | 935.63 on 03/03/25 | 169.99 on 03/04/25 | 218.66 on 03/10/25 | 93.80 on 02/25/25 |
3-Month | |||||
%Chg | -6.40% since 12/13/24 | +3.09% since 12/13/24 | +11.04% since 12/13/24 | +22.15% since 12/13/24 | -27.86% since 12/13/24 |
Low | 17.00 on 03/13/25 | 725.01 on 01/17/25 | 140.68 on 01/10/25 | 168.06 on 01/22/25 | 73.80 on 03/12/25 |
High | 19.39 on 01/27/25 | 935.63 on 03/03/25 | 169.99 on 03/04/25 | 218.66 on 03/10/25 | 109.88 on 12/16/24 |
6-Month | |||||
%Chg | -12.22% since 09/13/24 | -11.93% since 09/13/24 | -1.64% since 09/13/24 | +9.04% since 09/13/24 | -43.69% since 09/13/24 |
Low | 17.00 on 03/13/25 | 711.40 on 11/18/24 | 140.68 on 01/10/25 | 163.81 on 11/19/24 | 73.80 on 03/12/25 |
High | 21.28 on 11/12/24 | 939.86 on 09/20/24 | 169.99 on 03/04/25 | 218.66 on 03/10/25 | 138.22 on 09/16/24 |
Key Statistics | |||||
Market Capitalization, $K | 1,089,936 | 771,317,248 | 392,347,328 | 373,849,248 | 346,213,120 |
Shares Outstanding, K | 62,676 | 948,170 | 2,409,848 | 1,765,355 | 4,487,532 |
Annual Sales | 358,710,000 | 45,042,700,000 | 88,821,000,000 | 56,334,000,000 | 42,108,430,000 |
Annual Net Income | 23,390,000 | 10,590,000,000 | 14,066,000,000 | 4,278,000,000 | 14,643,260,000 |
Last Quarter Sales | 91,810,000 | 13,532,800,000 | 22,520,000,000 | 15,102,000,000 | 12,261,320,000 |
Last Quarter Net Income | 20,330,000 | 4,409,800,000 | 3,431,000,000 | -22,000,000 | 4,026,620,000 |
60-Month Beta | 0.56 | 0.34 | 0.47 | 0.61 | 0.42 |
Per-Share Information | |||||
Most Recent Earnings | 0.57 on 02/26/25 | 5.32 on 02/06/25 | 2.04 on 01/22/25 | 2.16 on 01/31/25 | 0.91 on 02/05/25 |
Latest Earnings Date | 03/06/25 | 04/29/25 | 04/15/25 | 04/25/25 | 05/01/25 |
Most Recent Dividend | 0.250 on 09/08/15 | 1.500 on 02/14/25 | 1.240 on 02/18/25 | 1.640 on 01/15/25 | 0.362 on 08/16/24 |
Next Ex-Dividends Date | 09/08/15 | 02/14/25 | 02/18/25 | 04/15/25 | 03/31/25 |
Ratios | |||||
Price/Earnings ttm | 10.05 | 61.67 | 16.32 | 20.90 | 23.07 |